{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:29:15Z","timestamp":1780450155381,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["24590708"],"award-info":[{"award-number":["24590708"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jiac.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T20:31:04Z","timestamp":1495139464000},"page":"517-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli"],"prefix":"10.1016","volume":"23","author":[{"given":"Yoshifusa","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015fil","family":"Inan-Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Fukuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuha","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hibino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Ugajin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.04.006_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.006_bib2","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","article-title":"The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"17","author":"Doi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.006_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.006_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3947\/ic.2013.45.4.415","article-title":"Outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing enterobacteriaceae","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jiac.2017.04.006_bib5","series-title":"Performance standards for antimicrobial susceptibility testing: 19th informational supplement","author":"Clinical and Laboratory Standards","year":"2009"},{"key":"10.1016\/j.jiac.2017.04.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2333794X15625297","article-title":"Validation of cefazolin as initial antibiotic for first upper urinary tract infection in children","volume":"3","author":"Abe","year":"2016","journal-title":"Global Pediatric Health"},{"key":"10.1016\/j.jiac.2017.04.006_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.67.3.392","article-title":"Medical versus surgical treatment of primary vesicoureteral reflux: report of the international reflux study committee","volume":"67","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.04.006_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jac\/dkt387","article-title":"Emergence of extended-spectrum \u03b2-lactamase (ESBL) CTX-M-8 in Germany","volume":"69","author":"Eller","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.04.006_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/1040841X.2012.691460","article-title":"Epidemiology and genetics of CTX-M extended-spectrum \u03b2-lactamases in gram-negative bacteria","volume":"39","author":"Zhao","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jiac.2017.04.006_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn463","article-title":"Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread","volume":"63","author":"Suzuki","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.04.006_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1099\/jmm.0.059279-0","article-title":"Community spread of extended-spectrum \u03b2-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan","volume":"62","author":"Chong","year":"2013","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jiac.2017.04.006_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jpeds.2013.06.078","article-title":"Urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing and nonproducing bacteria: a comparative study","volume":"163","author":"Dayan","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2017.04.006_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2015.00045","article-title":"Epidemiology and characteristics of urinary tract infections in children and adolescents","volume":"5","author":"Hanna-Wakim","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2017.04.006_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.11150\/kansenshogakuzasshi.85.481","article-title":"[Four infants with upper urinary tract infection due to extended-spectrum \u03b2 lactamase (ESBL)-producing Escherichia coli]","volume":"85","author":"Hibino","year":"2011","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2017.04.006_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jiac.2015.06.006","article-title":"Emergence of antimicrobial-resistant uropathogens isolated from pediatric patients with cystitis on daily clean intermittent catheterization","volume":"21","author":"Hiyama","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.04.006_bib16","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.04.006_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2014.08.018","article-title":"Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"29","author":"Asakura","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.006_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.165.12.1375","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection","volume":"165","author":"Hyle","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2017.04.006_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/INF.0b013e31820d7ec4","article-title":"Outcome of urinary tract infections caused by extended spectrum \u03b2-lactamase-producing enterobacteriaceae in children","volume":"30","author":"Tratselas","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.04.006_bib20","first-page":"165","article-title":"Vital signs: carbapenem-resistant enterobacteriaceae","volume":"62","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2017.04.006_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0009922814555974","article-title":"Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection","volume":"54","author":"Sakran","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jiac.2017.04.006_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5455\/medarh.2014.68.239-243","article-title":"Bacterial uropathogens isolates and antibiograms in children under 5 years of age","volume":"68","author":"Alsammani","year":"2014","journal-title":"Med Arch"},{"key":"10.1016\/j.jiac.2017.04.006_bib23","first-page":"56","article-title":"Is combination antimicrobial therapy required for urinary tract infection in children?","volume":"36","author":"Lu","year":"2003","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2017.04.006_bib24","first-page":"778","article-title":"Laboratory and clinical studies on cefazolin, a new derivative of semisynthetic cephalosporin","volume":"18","author":"Seiga","year":"1970","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2017.04.006_bib25","first-page":"570","article-title":"Fundamental and clinical studies of cefotaxime in the pediatric field","volume":"28","author":"Motohiro","year":"1980","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2017.04.006_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5409\/wjcp.v4.i2.25","article-title":"Pyuria in patients with Kawasaki disease","volume":"4","author":"Watanabe","year":"2015","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.jiac.2017.04.006_bib27","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1542\/peds.2005-0559","article-title":"Infections and Kawasaki disease: implications for coronary artery outcome","volume":"116","author":"Benseler","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2017.04.006_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1442-200X.2009.02884.x","article-title":"Pyuria is not always sterile in children with Kawasaki disease","volume":"52","author":"Jan","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2017.04.006_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/AAC.48.2.392-395.2004","article-title":"Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance","volume":"48","author":"Bantar","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:18Z","timestamp":1761159378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1341321X17300910"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}